Allergology International (Jul 2024)
Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
- Chio Sakai,
- Masashi Matsuyama,
- Masayuki Nakajima,
- Sosuke Matsumura,
- Mizu Nonaka,
- Naoki Arai,
- Kenya Kuramoto,
- Kazufumi Yoshida,
- Yuko Morishima,
- Masafumi Muratani,
- Nobuyuki Hizawa
Affiliations
- Chio Sakai
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Masashi Matsuyama
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan; Corresponding author. Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8575, Japan.
- Masayuki Nakajima
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Sosuke Matsumura
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Mizu Nonaka
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Naoki Arai
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Kenya Kuramoto
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Kazufumi Yoshida
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Yuko Morishima
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Masafumi Muratani
- Department of Genome Biology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Nobuyuki Hizawa
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
- Journal volume & issue
-
Vol. 73,
no. 3
pp. 473 – 476
